SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001144204-16-079356
Filing Date
2016-02-05
Accepted
2016-02-05 17:29:28
Documents
4
Period of Report
2016-01-29
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 AMENDMENT TO FORM 8-K v430785_8ka.htm 8-K/A 11144
2 EXHIBIT 16.1 v430785_ex16-1.htm EX-16.1 7439
3 GRAPHIC image_001.gif GRAPHIC 4964
4 GRAPHIC image_001.jpg GRAPHIC 3449
  Complete submission text file 0001144204-16-079356.txt   31590
Mailing Address 165 LUDLOW AVENUE NORTHVALE NJ 07647
Business Address 165 LUDLOW AVENUE NORTHVALE NJ 07647 2017502646
ELITE PHARMACEUTICALS INC /NV/ (Filer) CIK: 0001053369 (see all company filings)

IRS No.: 223542636 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-15697 | Film No.: 161393367
SIC: 2834 Pharmaceutical Preparations